Google Ads is one of the few channels where an aesthetic practice can capture a patient at the exact moment they type "botox near me" or "lip filler consultation." But Google treats medical aesthetics differently from almost every other vertical. Prescription drug terms, before-and-after images, outcome guarantees, and even the word "Botox" itself are subject to layered restrictions that change by country, certification status, and where the term appears — ad copy, keyword, or landing page.
This article is for med spa owners, practice managers, and marketing teams running (or planning to run) Google Ads for aesthetic services. It covers the specific policy layers that apply, the certification paths available, how to structure campaigns and landing pages for compliance, and how to track conversions without running afoul of Google's misrepresentation rules.
The Policy Framework That Governs Aesthetic Ads
Google's enforcement sits on three overlapping policies:
- Healthcare and Medicines policy — governs what health-related content can be advertised, by whom, and in which countries. This is the primary gate for aesthetic clinics.
- Restricted Drug Terms — a subset of the healthcare policy that lists specific prescription drug names and active ingredients. Using these terms in ad copy, keywords, or landing pages triggers additional requirements.
- Misrepresentation policy — prohibits misleading claims, including guarantees of specific outcomes, before-and-after imagery in ads, and unsubstantiated medical claims.
All three apply simultaneously. An ad can pass the drug-term filter but fail misrepresentation. A landing page can be policy-compliant on its own but trigger a drug-term violation if Google's crawler finds a restricted term anywhere on the linked site.
Restricted Drug Terms: What Triggers and What Does Not
Google maintains a non-exhaustive list of prescription drug names and active ingredients monitored under its restricted drug terms policy. The list includes botulinum toxin products (Botox, Dysport, Xeomin, Daxxify, Jeuveau), hyaluronic acid fillers marketed as medical devices (Juvéderm, Restylane, Sculptra), semaglutide, tirzepatide, and hundreds of other prescription substances.
The key rules differ by the advertiser's target country:
United States, Canada, and New Zealand. Advertisers may use prescription drug terms for promotional purposes — in ad copy, keywords, and landing pages — but only with proper certification. In the US, this means either Google's own healthcare certification or LegitScript Healthcare Merchant Certification.
United Kingdom, European Union, Australia, and most other markets. Prescription drug terms cannot be used in ads at all, regardless of certification. The UK is explicit: Botox is a Prescription-Only Medicine (POM), and advertising POMs to the public is prohibited. Clinics in these markets must use generic language like "anti-wrinkle injections" or "line softening treatments" instead.
What Google crawls. The policy applies not just to the ad itself but to the landing page and the broader website the ad links to. Google's systems crawl the destination URL and will flag restricted terms found anywhere on the site — including treatment pages, blog posts, and footer menus that the ad does not directly reference. This is a common trap: the ad copy uses compliant language, but the landing page site mentions "Botox" in the navigation, and the entire campaign gets disapproved.
Trademark complications
Even when drug-term policy allows use of a name, the trademark owner (Allergan for Botox, Galderma for Restylane, etc.) can file a complaint. Google's trademark policy for healthcare allows brand owners to restrict unauthorized use of their marks in ad copy. Practices that are authorized retailers or medical providers can appeal, but the process takes time and is not guaranteed.
Certification Paths for US Aesthetic Practices
US-based aesthetic practices that want to bid on prescription drug terms or mention them in ad copy have two primary certification routes:
Google Healthcare Certification
Google offers a direct healthcare advertising certification for licensed medical providers. The application requires:
- Proof of active medical licensing (physician, NP, PA, or RN with prescriptive authority as appropriate)
- Business registration documentation
- A website that clearly identifies the practice, its licensed providers, and the services offered
- Compliance with all applicable state and federal advertising regulations
Google reviews the application and, if approved, enables the advertiser to use prescription drug terms in campaigns targeting the US. The certification is tied to the Google Ads account and must be maintained.
LegitScript Healthcare Merchant Certification
LegitScript is a third-party certification body recognized by Google, Meta, TikTok, and payment processors. LegitScript certification is:
- Required for telemedicine advertisers that facilitate prescribing
- Strongly recommended for med spas that advertise prescription-based treatments, including Botox and fillers
- Recognized across multiple ad platforms (not just Google), making it the broader credential
The LegitScript process reviews the practice's licensing, business practices, website content, prescribing protocols, advertising compliance, and patient privacy protections. Total costs (application fee plus annual certification fee) typically run $1,000–$2,000 per site, with annual renewal required. Review typically takes two to six weeks.
Which path to choose
For a brick-and-mortar med spa that only advertises on Google, the direct Google healthcare certification may be sufficient. For practices that also advertise on Meta platforms, offer telemedicine consultations, or process virtual payments, LegitScript provides broader platform access. Many practices hold both.
Campaign Structure for Compliance
Separate ad groups by treatment category
Do not mix injectable ads with general skincare or body contouring in the same ad group. Each treatment category should have its own ad group with tightly themed keywords. This limits the blast radius if one ad group triggers a policy review — the rest of the campaign stays live.
Keyword strategy
In the US with certification, practices can bid on terms like "Botox [city]," "dermal filler near me," and branded treatment names. Without certification, or in restricted markets, keywords must use generic language:
- "anti-wrinkle treatment [city]"
- "wrinkle relaxer consultation"
- "lip enhancement [city]"
- "non-surgical facial rejuvenation"
An aggressive negative keyword list is essential. Terms like "cheap," "free," "DIY," and "at home" should be excluded to avoid low-intent clicks and to distance the campaign from policy-sensitive content.
Ad copy rules
Ad copy for aesthetic services must avoid:
- Before-and-after images or descriptions. Google explicitly prohibits before-and-after imagery in healthcare ads. This includes text like "see the transformation" or "look 10 years younger."
- Outcome guarantees. Phrases like "results in 24 hours," "100% satisfaction," or "permanent wrinkle removal" violate the misrepresentation policy.
- Sensational language. "Perfect," "flawless," "miraculous," and "painless" are common triggers for policy review.
- Personalization targeting insecurities. Google's personalized advertising policy restricts ads that target users based on perceived health conditions or insecurities about appearance.
Compliant ad copy focuses on the service and the consultation: "Board-certified provider," "schedule a consultation," "customized treatment plan," "FDA-cleared technology."
Landing Page Requirements
Google evaluates the landing page just as rigorously as the ad itself. For aesthetic practices:
What the landing page must have
- Clear provider identification. Names, credentials, and license types of all providers must be visible.
- Service descriptions that are factual, not promotional. Describe what the treatment involves, not what outcome the patient will achieve.
- Pricing transparency. Providing price ranges (e.g., "Botox: $12–$15/unit, typical treatment $250–$450") builds trust and pre-qualifies leads. Practices that hide pricing behind "contact us for a quote" see lower conversion rates.
- Contact information and booking functionality. The page must make it easy to schedule a consultation.
- Compliance with HIPAA if patient data is collected. Any form that collects health information must have appropriate privacy disclosures.
What the landing page must avoid
- Unsubstantiated clinical claims
- Testimonials that imply guaranteed outcomes
- Stock photos that could be misleading (practices that use authentic team and facility photography generally report stronger engagement than those relying on stock imagery)
- Links to pages that contain restricted drug terms if the practice is not certified
The separate-site strategy
Some practices maintain two versions of their website: a full clinical site that uses prescription drug names in treatment descriptions (for organic SEO) and a separate, policy-compliant site used exclusively as the Google Ads landing page. This is legitimate but requires care — the compliant site must be a real, functional page, not a thin redirect. Google penalizes doorway pages that exist only to route traffic.
Conversion Tracking
Conversion tracking for aesthetic practices is more complex than for e-commerce because the key action — a booked consultation — may happen through multiple channels: online booking form, phone call, or email.
Recommended tracking stack
- Google Tag Manager — deploy and manage all tracking pixels without editing site code. Tag Manager supports consent-based firing, which is required if the practice collects health information.
- Google Ads conversion actions — configure at minimum four conversion types:
- Form submissions (online booking)
- Phone calls (using Google forwarding numbers)
- Click-to-call on mobile
- Appointment confirmation page views
- GA4 integration — connect Google Ads to GA4 for cross-channel attribution. This reveals which keywords and campaigns drive actual bookings versus just clicks.
- Offline conversion imports — for practices where the consultation happens in person, Google's offline conversion import links ad clicks to in-office outcomes. This closes the loop between ad spend and revenue.
Privacy considerations
Healthcare advertisers must comply with HIPAA when tracking user behavior. This means:
- Do not pass protected health information (PHI) through URL parameters or form fields that Google's tracking can capture
- Obtain user consent before firing tracking pixels where required by state law (CCPA, state health privacy laws)
- Use consent mode in Google Tag Manager to conditionally fire tags based on user preference
Performance benchmarks
Based on practice marketing data for 2025–2026:
- Healthy cost per acquisition (CPA) for non-surgical treatments: $50–$150 per booked consultation
- Return on ad spend (ROAS) for established campaigns: 4:1 to 8:1 for non-surgical treatments
- Click-through rates for aesthetic search ads: 3–6% on branded terms, 1–3% on generic treatment terms
- Average conversion rate from landing page to booked consultation: 5–12%
Campaigns in the first two months typically underperform these benchmarks while Google's algorithm optimizes delivery. Practices should plan for a ramp-up period before evaluating ROI.
Platform-Specific Notes
Performance Max
Performance Max campaigns can deliver strong results for aesthetic practices when fed high-quality audience signals, custom asset groups per treatment category, and proper exclusion lists. However, PMax gives the advertiser less control over where ads appear. Practices should monitor placement reports closely and exclude irrelevant or brand-unsafe surfaces.
YouTube and video campaigns
For higher-ticket treatments — body contouring, full-face packages, surgical-adjacent procedures — video ads on YouTube can reduce cost per lead by 20–30% by warming prospects before they reach the search ad. Video content must comply with the same healthcare policies as search ads: no before-and-after imagery, no outcome guarantees, no restricted drug terms without certification.
Remarketing
Remarketing is permitted for aesthetic services but must not target users based on health conditions or perceived insecurities. Audience lists should be built from site visitors generally, not from pages visited about specific conditions. Google's Health in Personalized Advertising policy prohibits targeting based on physical health conditions, invasive procedures (including cosmetic surgery), and treatments for chronic conditions.
Common Reasons Campaigns Get Disapproved
Practices new to Google Ads in aesthetics often encounter repeated disapprovals. The most common causes:
- Restricted drug term on the landing page site — even if the ad itself is compliant, Google crawls the entire site. A treatment page that mentions "Botox" will flag the campaign if the advertiser lacks certification.
- Before-and-after imagery — including before-and-after photos on the landing page linked from the ad, not just in the ad itself.
- Misleading claims — any language that promises specific outcomes, timelines, or "transformation" results.
- Missing certification — attempting to bid on drug-term keywords without completing Google's healthcare certification or LegitScript.
- Trademark complaint — a manufacturer filed a complaint about unauthorized use of their brand name.
Each disapproval requires a manual appeal. Google's review process can take days, during which the campaign is paused. Practices should build compliance review into their standard operating procedure before launching new ads, not after disapproval.
A Compliance Checklist Before Launching
Before a practice runs its first Google Ads campaign for aesthetic services:
- Confirm target country restrictions and whether prescription drug terms are permitted
- Complete Google Healthcare Certification or LegitScript certification if planning to use drug terms
- Audit the entire landing page website for restricted drug terms, before-and-after images, and outcome guarantees
- Structure campaigns with separate ad groups per treatment category
- Write ad copy that describes the service, not the outcome
- Build a negative keyword list that excludes low-intent and policy-sensitive terms
- Set up conversion tracking through Tag Manager with consent mode
- Verify that no PHI passes through tracking parameters
- Monitor placement reports weekly in the first month
- Designate a team member (or agency) responsible for responding to policy disapprovals within 24 hours
Sources
- Google Ads, "Healthcare and medicines" advertising policy: https://support.google.com/adspolicy/answer/176031
- Google Ads, "Restricted drug terms" policy: https://support.google.com/adspolicy/answer/15595717
- Search Engine Land, "Google Ads loosens prescription drug term restrictions for non-promotional use" (May 2026): https://searchengineland.com/google-certification-prescription-drug-advertising-463409
- Lengea Law, "Google's Prescription Drug Advertising Enforcement" (September 2025): https://lengealaw.com/googles-prescription-drug-advertising-enforcement-what-your-business-needs-to-know
- Dean Garland Insights, "Google Ads Requirements for Med Spas, Pharmaceuticals, and Healthcare Services" (September 2025): https://www.deangarland.com/insights/google-ads-med-spa-requirements
- LegitScript, "Building Consumer Trust: Essential Compliance, Marketing, & Safety Measures for Medical Spas": https://www.legitscript.com/healthcare/essential-compliance-marketing-and-safety-for-med-spas
- Accelerated Digital Media, "2026 Search Advertising Rules for Health Brands": https://www.accelerateddigitalmedia.com/insights/health-policies-and-restrictions-guide-for-google-ads-microsoft-ads-2026
- Pracxcel, "Running Google Ads for Cosmetic Injectables: Dos and Don'ts in 2026": https://pracxcel.com.au/running-google-ads-for-cosmetic-injectables-dos-and-donts-in-2026
- Toopixels, "Google Ads for Aesthetic Clinics — 2026 Guide": https://toopixels.com/google-ads-for-aesthetic-clinics
- Wolfable, "Medical Advertising Regulations by Country: The 2026 Compliance Guide": https://wolfable.com/medical-advertising-regulations-compliance-guide
